Journal of the Formosan Medical Association (Mar 2020)
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
- Yi-Heng Li,
- Jaw-Wen Chen,
- Tsung-Hsien Lin,
- Yu-Chen Wang,
- Chau-Chung Wu,
- Hung-I Yeh,
- Chin-Chou Huang,
- Kuan-Cheng Chang,
- Cho-Kai Wu,
- Po-Wei Chen,
- Chen-Wei Huang,
- Zhih-Cherng Chen,
- Wei-Ting Chang,
- Wei-Chun Huang,
- Chih-Yuan Wang,
- Mei-Yueh Lee,
- A-Ching Chao,
- Wei-Ren Fu,
- Li-Kai Tsai,
- Sung-Chun Tang,
- Hsin-Lung Chan,
- Yi-Ching Yang,
- Yen-Wen Wu,
- Juey-Jen Hwang,
- Jiunn-Lee Lin
Affiliations
- Yi-Heng Li
- Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Jaw-Wen Chen
- Department of Medical Research and Education, Taipei Veterans General Hospital and Institute of Pharmacology, National Yang Ming University, Taipei, Taiwan
- Tsung-Hsien Lin
- Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Yu-Chen Wang
- Division of Cardiology, Department of Internal Medicine, Asia University Hospital, China Medical University College of Medicine and Hospital, Taichung, Taiwan
- Chau-Chung Wu
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and Graduate Institute of Medical Education & Bioethics, College of Medicine, National Taiwan University, Taipei, Taiwan
- Hung-I Yeh
- Department of Internal Medicine and Medical Research, Mackay Memorial Hospital, Taipei, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan
- Chin-Chou Huang
- Department of Medical Education, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan
- Kuan-Cheng Chang
- Division of Cardiovascular Medicine, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan
- Cho-Kai Wu
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
- Po-Wei Chen
- Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Chen-Wei Huang
- Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Zhih-Cherng Chen
- Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan; Department of Pharmacy, Chia Nan University of Pharmacy & Science, Tainan, Taiwan
- Wei-Ting Chang
- Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan
- Wei-Chun Huang
- Division of Cardiology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- Chih-Yuan Wang
- Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- Mei-Yueh Lee
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- A-Ching Chao
- Department of Neurology, Kaohsiung Medical University Hospital, Taiwan; Graduate Institute of Clinical Medicine and Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Wei-Ren Fu
- Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan
- Li-Kai Tsai
- Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
- Sung-Chun Tang
- Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
- Hsin-Lung Chan
- Department of Family Medicine, Mackay Memorial Hospital, Department of Medicine, Mackay Medical College, Taipei, Taiwan
- Yi-Ching Yang
- Department of Family Medicine, National Cheng Kung University Hospital, Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Yen-Wen Wu
- Cardiology Division, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan; National Yang-Ming University School of Medicine, Taipei, Taiwan
- Juey-Jen Hwang
- Cardiology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin, Yun-Lin, Taiwan; Corresponding author. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan.
- Jiunn-Lee Lin
- Cardiology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan; Corresponding author. Cardiovascular Center, Taipei Medical University Shuang Ho Hospital, No. 291 Zhong-zheng Road, Zhonghe District, New Taipei City, Taiwan.
- Journal volume & issue
-
Vol. 119,
no. 3
pp. 674 – 684
Abstract
Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations. Keywords: Atherosclerosis, Risk factors, Performance guide
